SCHEMBL19429286

SCHEMBL19429286

Brc1cccc(-c2ccccc2N(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TSHR P16473 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
GABRA1 P14867 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
BIRC5 O15392 1/20 0.38
MAOB P27338 2/20 0.38
ALDH1A1 P00352 5/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 2/20 0.37
IDO1 P14902 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 1/20 0.37
CHRNB4 P30926 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24897172 0.92 ALDH1A1 (0.39) NPC1SMN1; SMN2TSHRRAB9ATP53
SCHEMBL30046142 0.92 ALDH1A1 (0.39) NPC1SMN1; SMN2TSHRRAB9ATP53
SCHEMBL15587729 0.90 ALDH1A1 (0.40) NPC1SMN1; SMN2TSHRRAB9ATP53
SCHEMBL19429290 0.84 NPC1 (0.42) NPC1SMN1; SMN2TSHRRAB9ATP53
SCHEMBL18090461 0.83 ALDH1A1 (0.39) MAOBALDH1A1HTTMAPTHPGD
SCHEMBL18859311 0.82 ALDH1A1 (0.45) NPC1SMN1; SMN2RAB9AALDH1A1MAPT
SCHEMBL24224732 0.82 ALDH1A1 (0.41) ALDH1A1MAPTMEN1KMT2ATDP1
SCHEMBL16385320 0.82 L3MBTL1 (0.36) NPC1SMN1; SMN2RAB9AALDH1A1HTT
SCHEMBL29511964 0.81 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL733459 0.81 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF OCIAD1, GPX1, PIEZO1 NPC1 2748/4885SMN1; SMN2 1301/4885TSHR 4510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.